UCENTRIS
Dead / Abandoned — Abandoned — no statement of use filed (as of 16 Dec 2019)
What this means for you
This application is over — abandoned 16 Dec 2019. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88014395
- Mark type
- Stylized text
- Filed
- 25 Jun 2018
- Published for opposition
- 18 Sept 2018
- Abandoned
- 16 Dec 2019
- Attorney of record
- Adam Rodriguez
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans for the prevention and treatment of oncological, dermatological, neurological, respiratory, psychiatric and rare diseases, disorders and conditions
- Class 040 — Treatment of materials: Manufacturing of pharmaceuticals for others
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and medicines
Owner
- Acrotech Biopharma, LLC, East Windsor, NJ, US
- Acrotech Biopharma, LLC, East Windsor, NJ, US
Prosecution history
- 16 Dec 2019 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 16 Dec 2019 — ABANDONMENT - NO USE STATEMENT FILED
- 15 Mar 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2019 — SOU EXTENSION 1 GRANTED
- 13 Mar 2019 — SOU EXTENSION 1 FILED
- 13 Mar 2019 — SOU TEAS EXTENSION RECEIVED
- 13 Nov 2018 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 18 Sept 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Sept 2018 — PUBLISHED FOR OPPOSITION
- 29 Aug 2018 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Aug 2018 — ASSIGNED TO LIE
- 31 Jul 2018 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Jul 2018 — EXAMINER'S AMENDMENT ENTERED
- 30 Jul 2018 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 30 Jul 2018 — EXAMINERS AMENDMENT E-MAILED